IBDEI0HC ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8386,1,4,0)
 ;;=4^346.11
 ;;^UTILITY(U,$J,358.3,8386,2)
 ;;=^336829
 ;;^UTILITY(U,$J,358.3,8387,0)
 ;;=346.20^^52^581^65
 ;;^UTILITY(U,$J,358.3,8387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8387,1,3,0)
 ;;=3^Migraine,Cluster,Not Intractable
 ;;^UTILITY(U,$J,358.3,8387,1,4,0)
 ;;=4^346.20
 ;;^UTILITY(U,$J,358.3,8387,2)
 ;;=^336877
 ;;^UTILITY(U,$J,358.3,8388,0)
 ;;=346.21^^52^581^64
 ;;^UTILITY(U,$J,358.3,8388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8388,1,3,0)
 ;;=3^Migraine,Cluster,Intractable
 ;;^UTILITY(U,$J,358.3,8388,1,4,0)
 ;;=4^346.21
 ;;^UTILITY(U,$J,358.3,8388,2)
 ;;=^336830
 ;;^UTILITY(U,$J,358.3,8389,0)
 ;;=346.80^^52^581^66
 ;;^UTILITY(U,$J,358.3,8389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8389,1,3,0)
 ;;=3^Migraine,Ophthalmic
 ;;^UTILITY(U,$J,358.3,8389,1,4,0)
 ;;=4^346.80
 ;;^UTILITY(U,$J,358.3,8389,2)
 ;;=^336878
 ;;^UTILITY(U,$J,358.3,8390,0)
 ;;=350.1^^52^581^37
 ;;^UTILITY(U,$J,358.3,8390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8390,1,3,0)
 ;;=3^Fifth Nerve Palsy
 ;;^UTILITY(U,$J,358.3,8390,1,4,0)
 ;;=4^350.1
 ;;^UTILITY(U,$J,358.3,8390,2)
 ;;=^121978
 ;;^UTILITY(U,$J,358.3,8391,0)
 ;;=351.9^^52^581^15
 ;;^UTILITY(U,$J,358.3,8391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8391,1,3,0)
 ;;=3^CN VII Palsy
 ;;^UTILITY(U,$J,358.3,8391,1,4,0)
 ;;=4^351.9
 ;;^UTILITY(U,$J,358.3,8391,2)
 ;;=^109776
 ;;^UTILITY(U,$J,358.3,8392,0)
 ;;=356.9^^52^581^101
 ;;^UTILITY(U,$J,358.3,8392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8392,1,3,0)
 ;;=3^Peripheral Neuropathy
 ;;^UTILITY(U,$J,358.3,8392,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,8392,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,8393,0)
 ;;=357.0^^52^581^43
 ;;^UTILITY(U,$J,358.3,8393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8393,1,3,0)
 ;;=3^Guillain-Barre Syndrome
 ;;^UTILITY(U,$J,358.3,8393,1,4,0)
 ;;=4^357.0
 ;;^UTILITY(U,$J,358.3,8393,2)
 ;;=^2622
 ;;^UTILITY(U,$J,358.3,8394,0)
 ;;=358.00^^52^581^69
 ;;^UTILITY(U,$J,358.3,8394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8394,1,3,0)
 ;;=3^Myasthenia Gravis
 ;;^UTILITY(U,$J,358.3,8394,1,4,0)
 ;;=4^358.00
 ;;^UTILITY(U,$J,358.3,8394,2)
 ;;=^329920
 ;;^UTILITY(U,$J,358.3,8395,0)
 ;;=363.01^^52^581^39
 ;;^UTILITY(U,$J,358.3,8395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8395,1,3,0)
 ;;=3^Focal Choroiditis/Choriorentinitis
 ;;^UTILITY(U,$J,358.3,8395,1,4,0)
 ;;=4^363.01
 ;;^UTILITY(U,$J,358.3,8395,2)
 ;;=^268664
 ;;^UTILITY(U,$J,358.3,8396,0)
 ;;=363.05^^52^581^70
 ;;^UTILITY(U,$J,358.3,8396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8396,1,3,0)
 ;;=3^Neuroretinitis
 ;;^UTILITY(U,$J,358.3,8396,1,4,0)
 ;;=4^363.05
 ;;^UTILITY(U,$J,358.3,8396,2)
 ;;=^268667
 ;;^UTILITY(U,$J,358.3,8397,0)
 ;;=367.21^^52^581^11
 ;;^UTILITY(U,$J,358.3,8397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8397,1,3,0)
 ;;=3^Astigmatism
 ;;^UTILITY(U,$J,358.3,8397,1,4,0)
 ;;=4^367.21
 ;;^UTILITY(U,$J,358.3,8397,2)
 ;;=^265371
 ;;^UTILITY(U,$J,358.3,8398,0)
 ;;=367.52^^52^581^77
 ;;^UTILITY(U,$J,358.3,8398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8398,1,3,0)
 ;;=3^Ophthalmoplegia,Internal
 ;;^UTILITY(U,$J,358.3,8398,1,4,0)
 ;;=4^367.52
 ;;^UTILITY(U,$J,358.3,8398,2)
 ;;=^265383
 ;;^UTILITY(U,$J,358.3,8399,0)
 ;;=367.53^^52^581^4
 ;;^UTILITY(U,$J,358.3,8399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8399,1,3,0)
 ;;=3^Accommodation,Spasm
 ;;^UTILITY(U,$J,358.3,8399,1,4,0)
 ;;=4^367.53
 ;;^UTILITY(U,$J,358.3,8399,2)
 ;;=^265378
 ;;^UTILITY(U,$J,358.3,8400,0)
 ;;=368.01^^52^581^7
 ;;^UTILITY(U,$J,358.3,8400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8400,1,3,0)
 ;;=3^Amblyopia,Strabismic
